-
Archbishop Tutu Urges US Senate to Pass AIDS Bill
Archbishop Desmond Tutu of South Africa on Wednesday urged the U.S. Senate to pass a bill that would more than triple spending to fight AIDS, malaria and tuberculosis in Africa and other parts of the world.
Reuters Health Information, June 2008
-
African Americans With HIV at Greater Risk of Fatal Kidney Disease
African Americans with HIV infection are significantly more likely to encounter end-stage renal disease than are their white counterparts, researchers report in the June 1st issue of The Journal of Infectious Diseases.
Reuters Health Information, June 2008
-
HIV Screening May Be Cost Effective in Older Patients
Screening for HIV infection in patients older than 55 years of age is likely to be cost-effective if the prevalence of infection in the population is 0.1% or greater, according to a report in the Annals of Internal Medicine for June 17.
Reuters Health Information, June 2008
-
Mozambique to Build HIV/AIDS Drug Plant
Mozambique has approved the construction of a $23 million pharmaceutical plant that will manufacture drugs to treat HIV/AIDS, malaria and other diseases, the African nation's deputy health minister said on Friday.
Reuters Health Information, June 2008
-
South African Court Bans AIDS Vitamin Trials
A South African court on Friday issued an order banning unauthorised clinical trials of vitamin therapies for AIDS conducted by a team including a former adviser to President Thabo Mbeki.
Reuters Health Information, June 2008
-
High-Dose Cyclophosphamide Reduces Disability in Aggressive Multiple Sclerosis
High-dose cyclophosphamide reduces disease activity and disability in patients with severe aggressive multiple sclerosis who have not undergone bone marrow transplantation.
Medscape Medical News, June 2008
-
Better Counting Raises HIV Incidence Estimates in U.S.
Researchers have been undercounting new cases of HIV infection in the United States, meaning the rate is probably 25% higher at 50,000 people per year, according to Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
Reuters Health Information, June 2008
-
Head of UN's AIDS Program Piot to Step Down
The United Nations' top official in the global fight against AIDS, Dr. Peter Piot, is stepping down after 13 years, U.N. Secretary General Ban Ki-moon said on Tuesday.
Reuters Health Information, June 2008
-
Funding Gap for AIDS Help Persists: Global Fund
The Global Fund to Fight AIDS, Tuberculosis and Malaria requires another $7 billion to $8 billion to reach its funding goals for 2008, the fund's executive director, Michel Kazatchkine, said on Monday.
Reuters Health Information, June 2008
-
International Bodies Call for G8 Action on Health
Leaders of the Group of Eight (G8) rich nations meeting in Japan next month must tackle health scourges in developing countries to boost global prosperity and security, eight international organisations said on Monday.
Reuters Health Information, June 2008
-
Protease Inhibitors Safe, Effective in Antiretroviral-Experienced HIV-Infected Children
Treatment with the protease inhibitors (PI) ritonavir, nelfinavir, and lopinavir/ritonavir is safe and effective for the long-term treatment of antiretroviral-experienced HIV-infected children, according to a report in the May issue of The Pediatric Infectious Disease Journal.
Reuters Health Information, June 2008
-
Follicular Dendritic Cells Serve as HIV Reservoir
Follicular dendritic cells (FDCs) harbor large numbers of infectious, drug-resistant HIV, thereby contributing to virus transmission and persistence, scientists report in the June issue of the Journal of Virology.
Reuters Health Information, June 2008
-
Antidepressants Don't Influence Cancer Risk in HIV-Infected Individuals
The use of antidepressants does not affect the risk of cancer in individuals infected with HIV, according to a report in the May 10th Journal of Clinical Oncology.
Reuters Health Information, June 2008
-
Extended Antiretroviral Prophylaxis Reduces Breast-Milk HIV Transmission
In infants born to HIV-infected mothers, extended prophylaxis with nevirapine alone or combined with zidovudine for the first 14 weeks of life reduces their acquisition of HIV via breastfeeding, according to the results of a study conducted in Blantyre, Malawi.
Reuters Health Information, June 2008
-
HIV Vaccine Trial to Have Substantial Design Changes
As a result of the latest NIAID AVRS subcommittee meeting, the PAVE 100 study will likely have changes in the scientific questions asked, the endpoints measured, and the number and type of participants.
Medscape Medical News, June 2008
-
HIV Treatment Access Increases, but Coverage Still Low
As of the end of 2007, close to 3 million HIV-infected individuals in low- and middle-income nations had access to antiretroviral drug therapy (ART), representing an increase of nearly 950,000 people who received ART last year.
Reuters Health Information, June 2008
-
Most HIV-1 Infections Result From Single Virus
Most primary HIV-1 infections result from transmission of single virus lineages that are able to avoid the immune system, according to a report in the May 19th issue of PNAS Early Edition.
Reuters Health Information, May 2008
-
Simple Clinical Score Predicts Tuberculosis in HIV-Positive Children
A scoring scale based on readily available clinical information can help diagnose tuberculosis in HIV-positive children in rural areas, researchers from Rwanda reported recently at the annual meeting of the European Society for Paediatric Infectious Diseases held in Graz, Austria.
Reuters Health Information, May 2008
-
Many Non-AIDS-Defining Cancers More Common in HIV Patients
Several types of non-AIDS-defining cancers occur more frequently among HIV-infected individuals - particularly anal cancer - than in the general population, investigators report in the Annals of Internal Medicine for May 20th.
Reuters Health Information, May 2008
-
CME
Efavirenz May Be Best Initial Treatment of HIV-1 Infection
Patients given efavirenz plus 2 nucleoside reverse transcriptase inhibitors were less likely to have virologic failure than those given lopinavir-ritonavir.
Medscape Medical News, May 2008
